早期中心静脉置管对严重脓毒症患者死亡率的影响:一项全国住院患者数据库研究
该研究利用日本诊断程序组合数据库(2014年4月1日至2016年3月31日)进行全国性回顾性分析,纳入27,497例严重脓毒症患者中6,028例在入院30天内接受中心静脉置管的患者,其中4,544例(75.4%)在入院2天内接受早期置管。采用边际结构模型及逆概率治疗加权调整基线和时变治疗变量后,比较早期置管(2天内)与延迟置管(3天及以上)的30天死亡率。结果显示两组30天死亡率无显著差异(HR 0.83,95%CI 0.62-1.10)。结论认为在严重脓毒症患者中,早期中心静脉置管与住院死亡率改善无关。
要点
- 在严重脓毒症患者中,入院2天内早期中心静脉置管与3天及以上延迟置管相比,30天死亡率无显著差异(HR 0.83,95%CI 0.62-1.10)。
- 研究纳入6,028例来自911家医院的严重脓毒症患者,其中4,544例(75.4%)接受早期中心静脉置管。
- 早期置管组患者基线预后更差且接受更密集治疗,经边际结构模型调整后仍未见死亡率获益。
- 该研究为回顾性 nationwide 数据库分析,提示早期中心静脉置管本身可能并非改善严重脓毒症预后的关键因素。
适用人群与场景
- 严重脓毒症患者,来自日本全国住院患者数据库,入院30天内接受中心静脉置管者。
研究设计与关键结果
- 研究类型:全国性回顾性分析,使用日本诊断程序组合数据库(2014年4月1日至2016年3月31日)。
- 样本量:从27,497例严重脓毒症患者中识别出6,028例符合条件者,来自911家医院;4,544例(75.4%)接受早期中心静脉置管(入院2天内),其余接受延迟置管(入院3天及以上)。
- 主要终点:30天死亡率,采用边际结构模型及逆概率治疗加权调整基线和时变治疗变量后,早期置管组与延迟置管组相比无显著差异(HR 0.83,95%CI 0.62-1.10)。
- 基线特征:早期置管组患者预后基线更差且接受更密集治疗。
证据类型、等级与局限
- 证据类型:回顾性队列研究(全国住院患者数据库分析)。
- 局限:原文未报告局限性。
对床旁实践的改变
- 作者结论认为,在严重脓毒症患者中,早期中心静脉置管与住院死亡率改善无关。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
BACKGROUND: Clinical guidelines for the management of sepsis have accelerated the utilization of central venous catheterization (CVC). However, risks associated with CVC may be high in the initial phase of severe sepsis because of patient instability. The timing of CVC itself has not been fully evaluated. Therefore, we aimed to assess the association between CVC in the initial care of patients with severe sepsis and corresponding mortality rates.
PATIENTS AND METHODS: We conducted a nationwide retrospective analysis using the Japanese Diagnosis Procedure Combination database from April 1, 2014 to March 31, 2016. We identified patients who received CVC within 30 days from hospital admission. We compared the 30-day mortality between two groups: patients who received CVC within 2 days (early) after admission and those who received CVC 3 or more days (delayed) after admission, using marginal structural models with inverse probability treatment weighting.
RESULTS: We identified 6,028 eligible patients from 911 hospitals among 27,497 patients with severe sepsis for this study; 4,544 (75.4%) received early CVC. Patients with early CVC had poor prognostic baselines and received more intense treatment than patients with delayed CVC. After adjusting for baseline and time-dependent treatment variables, we found that there were no significant differences between patients who received CVC within 2 days after admission and those who received CVC 3 or more days after admission (hazard ratio 0.83, 95% confidence interval 0.62-1.10).
CONCLUSIONS: Among patients with severe sepsis, early CVC was not associated with improved in-hospital mortality rates.
参考来源
- Edakubo S, Inoue N, Fushimi K, et al. Effect of Early Central Venous Catheterization on Mortality Among Patients with Severe Sepsis: A Nationwide Inpatient Database Study. Shock. 2021. PMID: 32991796. doi:10.1097/SHK.0000000000001669
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。